Zealand Pharma A/S
ZLDPF
$61.00
$3.506.09%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.02B | -170.39M | -156.38M | -153.01M | -102.93M |
| Total Depreciation and Amortization | 3.20M | 3.24M | 3.36M | 3.36M | 3.06M |
| Total Amortization of Deferred Charges | 2.36M | 2.36M | 2.36M | 172.70K | 172.70K |
| Total Other Non-Cash Items | 149.22M | -1.32M | -2.01M | 12.32M | 12.95M |
| Change in Net Operating Assets | -22.74M | -7.21M | 17.42M | 36.28M | 12.92M |
| Cash from Operations | 1.16B | -173.33M | -135.26M | -100.87M | -73.81M |
| Capital Expenditure | -2.09M | -1.85M | -1.45M | -2.26M | -2.34M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 3.33M | 3.33M | -- | -- | -- |
| Other Investing Activities | -1.04B | -801.26M | -1.08B | -1.10B | -178.40M |
| Cash from Investing | -1.03B | -799.77M | -1.08B | -1.10B | -180.75M |
| Total Debt Issued | 0.00 | 0.00 | 369.87M | 369.87M | 369.87M |
| Total Debt Repaid | -17.53M | -16.92M | -16.44M | -20.49M | -18.99M |
| Issuance of Common Stock | 35.82M | 7.05B | 8.52B | 8.54B | 8.54B |
| Repurchase of Common Stock | -603.21M | -351.83M | -351.83M | -351.83M | -81.03M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.46M | -213.63M | -236.58M | -237.06M | -234.71M |
| Cash from Financing | -88.00M | 932.17M | 1.20B | 1.20B | 1.24B |
| Foreign Exchange rate Adjustments | -25.65M | -45.80K | 893.20K | -626.30K | 430.70K |
| Miscellaneous Cash Flow Adjustments | -100.00 | -100.00 | -100.00 | -100.00 | -- |
| Net Change in Cash | 7.45M | -40.99M | -15.57M | -1.82M | 985.56M |